Cargando…
Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
Endocan expression has been reported to be associated with aggressive tumor progression and poor outcomes in various cancers, such as breast cancer, renal cell cancer, lung cancer, gastric cancer, and pituitary adenomas. However, the prognostic significance of endocan in neuroendocrine tumors remain...
Autores principales: | Lin, Liang-Yu, Yeh, Yi-Chen, Chu, Chia-Huei, Won, Justin G.S., Shyr, Yi-Ming, Chao, Yee, Li, Chung-Pin, Wang, Shin-E, Chen, Ming-Huang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662320/ https://www.ncbi.nlm.nih.gov/pubmed/29019897 http://dx.doi.org/10.1097/MD.0000000000008262 |
Ejemplares similares
-
Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual
por: Deng, Ben-Yuan, et al.
Publicado: (2020) -
Treatment, prognostic markers, and survival in thymic neuroendocrine tumors: A single center experience of 41 patients
por: Ma, Kefeng, et al.
Publicado: (2017) -
Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study
por: Yang, You-Rong, et al.
Publicado: (2021) -
Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors: A SEER based study
por: Ge, Lina, et al.
Publicado: (2021) -
Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature
por: Tsoukalas, Nikolaos, et al.
Publicado: (2017)